Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Investment

Hearts & Minds revalues position amid Opthea fallout

Following Regal's lead, Hearts & Minds Investments has now also revalued its holding in Opthea following its failed clinical trials.

Upgrade your subscription to access this article

And gain access to:
  • All website content, including archived news
  • Home page news customisation
  • Tech Zone, your technical resource library
And more
Already A Subscriber?

Read more: OptheaRegalHearts & Minds InvestmentsHM1